Table 1.
ANS Assessment | Clinical Findings | References | Preclinical Findings | References |
---|---|---|---|---|
Blood pressure | Moderately higher systolic and diastolic blood pressure | [39] | ||
Blood pressure variability | No changes | [39] | ||
Heart rate variability | Reduced complexity | [7,46,47] | ||
Thermoregulation | Abnormal diurnal variation of body temperature | [48] | PCP rat model: Acute PCP: hypothermia Chronic PCP: hyperthermia Perinatal PCP: long-lasting effect on the baseline temperature |
[49,50] |
Impaired ability to heat stress adaptation Higher skin conductance Disturbed sympathetic skin responses |
[44,48,51,52,53,54,55,56,57,58,59,60] | Wisket rat model: Higher body temperature, Higher alteration rate |
[61] | |
Higher rate of sweating | [62] | |||
Pupil function | Increased resting pupil diameter | [8] | Wisket rat model: Sedation—several parameters disturbed Anesthesia—prolonged constriction and redilation processes, blunted differences |
[63] |
A “sluggish” parasympathetic function by light | [64] | |||
Decreased stimulus sensitivity | [12] | |||
Gastrointestinal system | Increased tachygastria, arrhythmia | [62] | ||
Delayed gastric emptying, diabetic gastroparesis | [62,65] | |||
Correlation between salivary α-amylase level and psychiatric symptoms | [66] | |||
Urinary system | Enhanced urinary frequency, urgency, incontinence and detrusor hyperreflexia | [67] | Wisket rat model: decreased bladder volume | [68] |
Abbreviations: ANS: autonomic nervous system, PCP: phencyclidine.